KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsFixed Assets, Net BreakdownGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome (Loss) Before Income TaxLicense Revenue By Category AnnualOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Trx By Product
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares OutstandingShares Outstanding
Ratios

TherapeuticsMD (TXMD) Gross Profit (2016 - 2025)

TherapeuticsMD filings provide 13 years of Gross Profit readings, the most recent being $502000.0 for Q4 2023.

  • On a quarterly basis, Gross Profit fell 99.27% to $502000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $1.3 million, a 98.43% decrease, with the full-year FY2023 number at $1.3 million, down 98.1% from a year prior.
  • Gross Profit hit $502000.0 in Q4 2023 for TherapeuticsMD, up from -$53000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $68.6 million in Q4 2022 to a low of -$53000.0 in Q3 2023.
  • Median Gross Profit over the past 5 years was $13.5 million (2019), compared with a mean of $13.6 million.
  • Biggest five-year swings in Gross Profit: skyrocketed 702.7% in 2019 and later crashed 99.27% in 2023.
  • TherapeuticsMD's Gross Profit stood at $13.0 million in 2019, then soared by 30.52% to $17.0 million in 2020, then dropped by 17.98% to $13.9 million in 2021, then skyrocketed by 391.83% to $68.6 million in 2022, then crashed by 99.27% to $502000.0 in 2023.
  • The last three reported values for Gross Profit were $502000.0 (Q4 2023), -$53000.0 (Q3 2023), and $437000.0 (Q2 2023) per Business Quant data.